BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 12784220)

  • 1. Crystal structure of the type II 3-dehydroquinase from Helicobacter pylori.
    Lee BI; Kwak JE; Suh SW
    Proteins; 2003 Jun; 51(4):616-7. PubMed ID: 12784220
    [No Abstract]   [Full Text] [Related]  

  • 2. Crystal structures of Helicobacter pylori type II dehydroquinase inhibitor complexes: new directions for inhibitor design.
    Robinson DA; Stewart KA; Price NC; Chalk PA; Coggins JR; Lapthorn AJ
    J Med Chem; 2006 Feb; 49(4):1282-90. PubMed ID: 16480265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of new nanomolar competitive inhibitors of Helicobacter pylori type II dehydroquinase. Structural details of the role of the aromatic moieties with essential residues.
    Prazeres VF; Tizón L; Otero JM; Guardado-Calvo P; Llamas-Saiz AL; van Raaij MJ; Castedo L; Lamb H; Hawkins AR; González-Bello C
    J Med Chem; 2010 Jan; 53(1):191-200. PubMed ID: 19911771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of NH3-dependent NAD+ synthetase from Helicobacter pylori.
    Kang GB; Kim YS; Im YJ; Rho SH; Lee JH; Eom SH
    Proteins; 2005 Mar; 58(4):985-8. PubMed ID: 15645437
    [No Abstract]   [Full Text] [Related]  

  • 5. Crystallization and preliminary X-ray crystallographic analysis of type II dehydroquinase from Helicobacter pylori.
    Kwak JE; Lee JY; Han BW; Moon J J; Sohn SH; Suh SW
    Acta Crystallogr D Biol Crystallogr; 2001 Feb; 57(Pt 2):279-80. PubMed ID: 11173479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of quinolinic acid phosphoribosyltransferase from Helicobacter pylori.
    Kim MK; Im YJ; Lee JH; Eom SH
    Proteins; 2006 Apr; 63(1):252-5. PubMed ID: 16419067
    [No Abstract]   [Full Text] [Related]  

  • 7. Crystal structure of HP0242, a hypothetical protein from Helicobacter pylori with a novel fold.
    Tsai JY; Chen BT; Cheng HC; Chen HY; Hsaio NW; Lyu PC; Sun YJ
    Proteins; 2006 Mar; 62(4):1138-43. PubMed ID: 16395670
    [No Abstract]   [Full Text] [Related]  

  • 8. Crystal structures of Staphylococcus aureus type I dehydroquinase from enzyme turnover experiments.
    Nichols CE; Lockyer M; Hawkins AR; Stammers DK
    Proteins; 2004 Aug; 56(3):625-8. PubMed ID: 15229896
    [No Abstract]   [Full Text] [Related]  

  • 9. Crystallization of a type II dehydroquinase from Mycobacterium tuberculosis.
    Gourley DG; Coggins JR; Isaacs NW; Moore JD; Charles IG; Hawkins AR
    J Mol Biol; 1994 Aug; 241(3):488-91. PubMed ID: 8064862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rational design of new bifunctional inhibitors of type II dehydroquinase.
    Toscano MD; Stewart KA; Coggins JR; Lapthorn AJ; Abell C
    Org Biomol Chem; 2005 Sep; 3(17):3102-4. PubMed ID: 16106291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of YagE, a putative DHDPS-like protein from Escherichia coli K12.
    Manicka S; Peleg Y; Unger T; Albeck S; Dym O; Greenblatt HM; Bourenkov G; Lamzin V; Krishnaswamy S; Sussman JL
    Proteins; 2008 Jun; 71(4):2102-8. PubMed ID: 18361457
    [No Abstract]   [Full Text] [Related]  

  • 12. 2-substituted-3-dehydroquinic acids as potent competitive inhibitors of type II dehydroquinase.
    Prazeres VF; Castedo L; Lamb H; Hawkins AR; González-Bello C
    ChemMedChem; 2009 Dec; 4(12):1980-4. PubMed ID: 19856378
    [No Abstract]   [Full Text] [Related]  

  • 13. Understanding the key factors that control the inhibition of type II dehydroquinase by (2R)-2-benzyl-3-dehydroquinic acids.
    Peón A; Otero JM; Tizón L; Prazeres VF; Llamas-Saiz AL; Fox GC; van Raaij MJ; Lamb H; Hawkins AR; Gago F; Castedo L; González-Bello C
    ChemMedChem; 2010 Oct; 5(10):1726-33. PubMed ID: 20815012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Competitive inhibitors of Helicobacter pylori type II dehydroquinase: synthesis, biological evaluation, and NMR studies.
    Sánchez-Sixto C; Prazeres VF; Castedo L; Suh SW; Lamb H; Hawkins AR; Cañada FJ; Jiménez-Barbero J; González-Bello C
    ChemMedChem; 2008 May; 3(5):756-70. PubMed ID: 18200648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovering potent inhibitors against the beta-hydroxyacyl-acyl carrier protein dehydratase (FabZ) of Helicobacter pylori: structure-based design, synthesis, bioassay, and crystal structure determination.
    He L; Zhang L; Liu X; Li X; Zheng M; Li H; Yu K; Chen K; Shen X; Jiang H; Liu H
    J Med Chem; 2009 Apr; 52(8):2465-81. PubMed ID: 19309082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structure of the Helicobacter pylori enoyl-acyl carrier protein reductase in complex with hydroxydiphenyl ether compounds, triclosan and diclosan.
    Lee HH; Moon J; Suh SW
    Proteins; 2007 Nov; 69(3):691-4. PubMed ID: 17879346
    [No Abstract]   [Full Text] [Related]  

  • 17. The two types of 3-dehydroquinase have distinct structures but catalyze the same overall reaction.
    Gourley DG; Shrive AK; Polikarpov I; Krell T; Coggins JR; Hawkins AR; Isaacs NW; Sawyer L
    Nat Struct Biol; 1999 Jun; 6(6):521-5. PubMed ID: 10360352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of dihydrodipicolinate synthase (BA3935) from Bacillus anthracis at 1.94 A resolution.
    Blagova E; Levdikov V; Milioti N; Fogg MJ; Kalliomaa AK; Brannigan JA; Wilson KS; Wilkinson AJ
    Proteins; 2006 Jan; 62(1):297-301. PubMed ID: 16287120
    [No Abstract]   [Full Text] [Related]  

  • 19. Crystal structure of UDP-N-acetylglucosamine acyltransferase from Helicobacter pylori.
    Lee BI; Suh SW
    Proteins; 2003 Nov; 53(3):772-4. PubMed ID: 14579368
    [No Abstract]   [Full Text] [Related]  

  • 20. Macromolecular crystal data phased by negative-stained electron-microscopy reconstructions.
    Trapani S; Schoehn G; Navaza J; Abergel C
    Acta Crystallogr D Biol Crystallogr; 2010 May; 66(Pt 5):514-21. PubMed ID: 20445226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.